• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Model Number 10-401FC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Uterine Perforation (2121)
Event Date 09/12/2019
Event Type  Injury  
Manufacturer Narrative
Lot and serial number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device is not being returned therefore, a failure analysis of the complaint device cannot be completed.If additional relevant information is received or device evaluation completed, a supplemental medwatch will be filed.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.Internal reference #: (b)(4).
 
Event Description
It was reported that during the procedure, prior to inserting the myosure device, the fluid deficit began to rise.The myosure device was inserted into the patient and the deficit continued to rise.They aborted the procedure when the deficit reached 1650 ml.The physician viewed the uterus via laparoscopy and noted the fundus was perforated.He put one stitch to seal the perforation.The patient was doing fine when hologic representative left the or.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
kelsea lyver
250 campus drive
marlborough, MA 01752
5082636130
MDR Report Key9144804
MDR Text Key161252113
Report Number1222780-2019-00229
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K152723
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10-401FC
Device Catalogue Number10-401FC
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/12/2019
Initial Date FDA Received10/02/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-